Nebenwirkungen · Tookad
TOOKAD 183 mg powder for solution for injection TOOKAD 366 mg powder for solution for injection · Abschnitt 4.8 · PDF-Seite 7
HOS-136017 · Präparat HOS-097808
Unspecific adverse events probably linked to the general anaesthesia were also observed: transient global amnesia, bradycardia, sinus arrhythmia, atrial fibrillation, hypotension, bronchospasm, pharyngeal inflammation, respiratory tract congestion, nausea, vomiting, constipation, pyrexia, procedural hypotension. Some cases of hepatotoxicity (1.5 %), such as elevation of transaminases, were also reported. All of them were mild in intensity.
Originalpassage; keine automatisch abgeleitete Schwere, Häufigkeit oder Kausalität. Auch verneinte Befunde und nicht untersuchte Kombinationen bleiben sichtbar.
Vollständigen Kontext in der EMA-Fachinformation lesen →Quellennachweis
Version 2022-12-07T01:00:00Z · SHA-256 86ab6205066703c9c0efe5f9fcb6f836848dd067cf287be0e096ac7a8110e9b4 · Passage 49e4e2527945f659654451382fb4a123eda44280fb8f7f0ef74c415e942a9bbf · Zeichen 436–879 im Abschnitt